Please login to the form below
PMBCL
This page shows the latest PMBCL news and features for those working in and with pharma, biotech and healthcare.
Gracell reports impressive data with one-day CAR-T for leukaemia
Meanwhile, Gilead reported $216m in first-half sales from DLBCL and another NHL variant called primary mediastinal large B-cell lymphoma (PMBCL).
Latest news
-
NHS chief pledges CAR-T support, but asks for pricing restraint
primary mediastinal B-cell lymphoma (PMBCL) and transformed follicular lymphoma (TFL).
-
Novartis files CAR-T therapy CTL109 in Europe
Kite was the first to file its new therapy in Europe, seeking approval in August for DLBCL, transformed follicular lymphoma (TFL), and primary mediastinal B-cell lymphoma (PMBCL) in adults ineligible
-
Kite starts EU trial of lead CAR-T therapy
Adult patients with DLBCL, PMBCL and TFL will be enrolled in the trial. ... Kite is currently enrolling adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma (PMBCL), and transformed follicular
-
Kite files first CAR-T candidate in Europe
cell lymphoma (PMBCL) who are ineligible for autologous stem cell transplant.
-
Kite Pharma soars after positive CAR-T data in lymphoma
B-cell lymphoma (PMBCL) - on the strength of the trial results.
More from news
Approximately 1 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC
- Saturnino Izquierdo takes on expanded role at McCann Health
- J&J delays EU COVID-19 vaccine rollout following pause in the US
- Moderna’s booster vaccine for South African variant demonstrates promising early results
- UK trial evaluating mixed-vaccine regimens includes two more jabs
- Follow the user – democratising medical conference design
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- How a design mindset can lead to better medical outcomes
- By adopting a design philosophy, healthcare companies can develop communications that allow healthcare professionals (HCPs) to better meet the needs of their patients. Imaginatively designed content combined with patient insights...
- How does the government plan to reshape the NHS?
- Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care...
- Want to give perfect client service? Tough luck, you’re human
- In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
Quick links
Infographics
